Parallel Advisors’s Vanguard Health Care ETF VHT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.75M | Sell |
6,422
-1,231
| -16% | -$352K | 0.03% | 331 |
|
|
2025
Q4 | $2.2M | Buy |
7,653
+372
| +5% | +$104K | 0.04% | 274 |
|
|
2025
Q3 | $1.89M | Sell |
7,281
-50
| -0.7% | -$12.5K | 0.03% | 292 |
|
|
2025
Q2 | $1.82M | Buy |
7,331
+59
| +0.8% | +$14.6K | 0.04% | 292 |
|
|
2025
Q1 | $1.92M | Buy |
7,272
+678
| +10% | +$181K | 0.04% | 258 |
|
|
2024
Q4 | $1.67M | Sell |
6,594
-298
| -4% | -$80.3K | 0.04% | 274 |
|
|
2024
Q3 | $1.94M | Buy |
6,892
+144
| +2% | +$40K | 0.05% | 254 |
|
|
2024
Q2 | $1.79M | Buy |
6,748
+363
| +6% | +$95.2K | 0.05% | 249 |
|
|
2024
Q1 | $1.73M | Sell |
6,385
-101
| -2% | -$26.5K | 0.05% | 255 |
|
|
2023
Q4 | $1.63M | Sell |
6,486
-1,399
| -18% | -$331K | 0.05% | 244 |
|
|
2023
Q3 | $1.85M | Sell |
7,885
-49
| -0.6% | -$11.9K | 0.06% | 206 |
|
|
2023
Q2 | $1.94M | Buy |
7,934
+282
| +4% | +$68.6K | 0.06% | 209 |
|
|
2023
Q1 | $1.82M | Buy |
7,652
+5,288
| +224% | +$1.27M | 0.06% | 213 |
|
|
2022
Q4 | $586K | Buy |
2,364
+274
| +13% | +$66.4K | 0.03% | 364 |
|
|
2022
Q3 | $468K | Buy |
2,090
+93
| +5% | +$22.2K | 0.02% | 405 |
|
|
2022
Q2 | $470K | Buy |
1,997
+1,048
| +110% | +$253K | 0.02% | 418 |
|
|
2022
Q1 | $244K | Buy |
949
+9
| +1% | +$2.22K | 0.01% | 659 |
|
|
2021
Q4 | $250K | Sell |
940
-62
| -6% | -$15.8K | 0.01% | 658 |
|
|
2021
Q3 | $248K | Sell |
1,002
-234
| -19% | -$60K | 0.01% | 644 |
|
|
2021
Q2 | $306K | Sell |
1,236
-90
| -7% | -$21.5K | 0.01% | 529 |
|
|
2021
Q1 | $303K | Buy |
1,326
+31
| +2% | +$7.11K | 0.01% | 494 |
|
|
2020
Q4 | $290K | Sell |
1,295
-59
| -4% | -$12.6K | 0.02% | 477 |
|
|
2020
Q3 | $276K | Buy |
1,354
+1
| +0.1% | +$202 | 0.02% | 453 |
|
|
2020
Q2 | $260K | Buy |
1,353
+1
| +0.1% | +$188 | 0.02% | 460 |
|
|
2020
Q1 | $224K | Sell |
1,352
-249
| -16% | -$45.5K | 0.02% | 414 |
|
|
2019
Q4 | $307K | Sell |
1,601
-5,783
| -78% | -$1.04M | 0.02% | 397 |
|
|
2019
Q3 | $1.24M | Sell |
7,384
-315
| -4% | -$53.9K | 0.11% | 150 |
|
|
2019
Q2 | $1.34M | Buy |
7,699
+355
| +5% | +$59.9K | 0.13% | 118 |
|
|
2019
Q1 | $1.27M | Sell |
7,344
-563
| -7% | -$95.4K | 0.14% | 114 |
|
|
2018
Q4 | $1.27M | Buy |
7,907
+846
| +12% | +$143K | 0.18% | 95 |
|
|
2018
Q3 | $1.27M | Buy |
7,061
+4,172
| +144% | +$717K | 0.16% | 111 |
|
|
2018
Q2 | $459K | Sell |
2,889
-1
| -0% | -$157 | 0.07% | 195 |
|
|
2018
Q1 | $444K | Sell |
2,890
-200
| -6% | -$31.9K | 0.07% | 189 |
|
|
2017
Q4 | $476K | Sell |
3,090
-434
| -12% | -$66.6K | 0.08% | 177 |
|
|
2017
Q3 | $533K | Sell |
3,524
-120
| -3% | -$17.9K | 0.09% | 158 |
|
|
2017
Q2 | $540K | Buy |
3,644
+335
| +10% | +$47.3K | 0.1% | 153 |
|
|
2017
Q1 | $463K | Buy |
3,309
+2,644
| +398% | +$356K | 0.09% | 161 |
|
|
2016
Q4 | $84K | Buy |
+665
| New | +$84.9K | 0.02% | 429 |
|
Other funds holding VHT
PCH
CI
EHC
Parallel Advisors's VHT Position: Q1 2026 in Review
Parallel Advisors reduced its Vanguard Health Care ETF (VHT) stake by 16% in Q1 2026, selling an estimated $352K and leaving 6,422 shares worth $1.75M. The position accounts for 0.03% of the portfolio, ranked #331.
Parallel Advisors first reported a position in VHT in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.2M in Q4 2025. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.
- Parallel Advisors held 6,422 shares of Vanguard Health Care ETF worth $1.75M as of Q1 2026.
- Parallel Advisors sold 1,231 Vanguard Health Care ETF shares in Q1 2026, an estimated $352K.
- Vanguard Health Care ETF made up 0.03% of Parallel Advisors's portfolio in Q1 2026, its #331 holding.
- Parallel Advisors first reported a position in Vanguard Health Care ETF in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's Vanguard Health Care ETF position peaked at $2.2M in Q4 2025.
- 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.